REFERENCES
- Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–1729.
- Reyburn B, Martin RJ, Prakash YS, et al. Mechanisms of injury to the preterm lung and airway: Implications for long-term pulmonary outcome. Neonatology 2012;101:345–352.
- Ozdemir R, Yurttutan S, Talim B, et al. Colchicine protects against hyperoxic lung injury in neonatal rats. Neonatology. 2012;102:265–269.
- Groneck P, Speer CP. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed. 1995;73:1–3.
- Van Marter LJ. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med. 2009;14:358–366.
- Polglase GR, Dalton RG, Nitsos I, et al. Pulmonary vascular and alveolar development in preterm lambs chronically colonized with ureaplasma parvum. Am J Physiol Lung Cell Mol Physiol. 2010;299:232–241.
- Viscardi RM, Atamas SP, Luzina IG, et al. Antenatal ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung. Pediatr Res. 2006;60:141–146.
- Stephens KE, Ishizaka A, Larrick JW, et al. Tumor necrosis factor causes increased pulmonary permeability and edema: Comparison to septic acute lung injury. Am Rev Respir Dis. 1988;137:1364–1370.
- Wherry JC, Pennington JE, Wenzel RP. Tumor necrosis factor and the therapeutic potential of antitumor necrosis factor antibodies. Crit Care Med. 1993;21:S436–S440.
- Sandborn WJ. New concepts in antitumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord. 2005;5:10–18.
- Yurttutan S, Ozdemir R, Canpolat FE, et al. Beneficial effects of etanercept on experimental necrotizing enterocolitis. Pediatr Surg Int. 2014;30:71–77.
- Olmos-Zuñiga JR, Jasso-Victoria R, Sotres-Vega A, et al. Suture-line reinforcement with glutaraldehyde-preserved bovine pericardium for nonanatomic resection of lung tissue. J Invest Surg. 2001;14:161–168.
- Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
- Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497–500.
- Tayman C, Cekmez F, Kafa IM, et al. Beneficial effects of Nigella sativa oil on intestinal damage in necrotizing enterocolitis. J Invest Surg. 2012;25:286–294.
- Wright CJ, Kirpalani H. Targeting inflammation to prevent bronchopulmonary dysplasia: Can new insights be translated into therapies? Pediatrics 2011;128:111–126.
- Kazzi SN, Kim UO, Quasney MW, et al. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 2004;114:e243–e248.
- Guthmann F, Wissel H, Rüstow B. Early subcutaneous administration of etanercept (Enbrel) prevents from hyperoxia-induced lung injury. Exp Lung Res. 2009;35:770–780.
- Li L, Das AM, Torphy TJ, et al. What's in the pipeline? Prospects for monoclonal antibodies (mAbs) as therapies for lung diseases. Pulm Pharmacol Ther. 2002;15:409–416.
- Ozer EA, Kumral A, Ozer E, et al. Effect of retinoic acid on oxygen-induced lung injury in the newborn rat. Pediatr Pulmonol. 2005;39:35–40.